Ventfort
Muscle/RecoveryKhavinson vascular bioregulator / researchExperimental
Vascular-wall bioregulator peptide from the Khavinson line. Not FDA-approved.
For research use only.
Key Facts
- CAS
- 143827-56-3
- Molecular Weight (MW)
- 405.36 g/mol
- Half-life
- Not established in humans
- Unit
- mcg
- Administration Route
- —
- Frequency
- —
- Last updated
- 8/23/2026
- Targets
- Endothelium (proposed)
Overview
Vascular-wall bioregulator peptide from the Khavinson line. Not FDA-approved.
Protocol
- Dosage Range
- Not established for human use
- Frequency
- —
- Cycle
- —
- Administration Route
- —
- Reconstitution Guide
- —
Science
Mechanism of Action
Claimed to support endothelial protein synthesis. Evidence is historical and not FDA-standard.
Targets
Endothelium (proposed)
Studies
- Khavinson bioregulators— Journal/year not available
Benefits
Historical vascular-bioregulator category
Potential Side Effects
- Not characterized
References
- PMID 15587334External link · Year —